Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GPX4 | P36969 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.36 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13515110 | 0.83 | FFAR4 (0.47) | GPR84FFAR1ALDH1A1 | |
| SCHEMBL2707024 | 0.81 | GPR84 (0.38) | FAAHNPC1RAB9APAX8JAK2 | |
| SCHEMBL17363778 | 0.79 | GPR84 (0.47) | GPR84CA1FFAR1MAPTLCK | |
| SCHEMBL15282992 | 0.79 | GPR84 (0.41) | GPR84CA1FFAR1MAPTLCK | |
| SCHEMBL16697104 | 0.77 | FDPS (0.47) | — | |
| SCHEMBL7157784 | 0.76 | PLA2G1B (0.39) | GPR84CA1FFAR1TP53MAPT | |
| SCHEMBL16697323 | 0.74 | FDPS (0.36) | PPARD | |
| SCHEMBL14229262 | 0.73 | CA2 (0.37) | CA1ALDH1A1CA2 | |
| SCHEMBL648953 | 0.73 | ZDHHC20 (0.41) | GPR84CA1FFAR1MAPTLCK | |
| SCHEMBL29218658 | 0.73 | GPR84 (0.46) | GPR84CA1FFAR1TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180333697-A1 | NOVEL ORGANIC MATERIAL FOR EXTRACTING THE URANIUM FROM AN AQUEOUS SOLUTION OF PHOSPHORIC ACID, ASSOCIATED METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM AND A PRECURSOR OF SUCH AN ORGANIC MATERIAL | Orano Mining (FR) | 2018-11-22 | — | — | US | disclosed |
| US-10130932-B2 | Organic-inorganic hybrid material of use for extracting uranium (VI) from aqueous media containing phosphoric acid, processes for preparing same and uses thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (FR) | 2018-11-20 | — | — | US | disclosed |
| US-10006103-B2 | Use of an organic-inorganic hybrid material for extracting uranium(VI) from a sulfuric acid aqueous solution, issued notably from the sulfuric leaching of a uranium-bearing ore | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2018-06-26 | — | — | US | disclosed |
| US-20160289796-A1 | USE OF AN ORGANIC-INORGANIC HYBRID MATERIAL FOR EXTRACTING URANIUM(VI) FROM A SULFURIC ACID AQUEOUS SOLUTION, ISSUED NOTABLY FROM THE SULFURIC LEACHING OF A URANIUM-BEARING ORE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2016-10-06 | — | — | US | disclosed |
| US-9441285-B2 | Bifunctional compounds useful as ligands of uranium (VI), methods of synthesising same and uses thereof | AREVA MINES (FR) | 2016-09-13 | — | — | US | disclosed |
| US-20160016150-A1 | ORGANIC-INORGANIC HYBRID MATERIAL OF USE FOR EXTRACTING URANIUM (VI) FROM AQUEOUS MEDIA CONTAINING PHOSPHORIC ACID, PROCESSES FOR PREPARING SAME AND USES THEREOF | UNIVERSITÉ DE MONTPELLIER (FR) | 2016-01-21 | — | — | US | disclosed |
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | AREVA MINES (FR) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | URB2, CHRM2, C1S | FAAH 1330/4885NPC1 2053/4885RAB9A 3069/4885 |
| US-20180333697-A1 | NOVEL ORGANIC MATERIAL FOR EXTRACTING THE URANIUM FROM AN AQUEOUS SOLUTION OF PHOSPHORIC ACID, ASSOCIATED METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM AND A PRECURSOR OF SUCH AN ORGANIC MATERIAL | UGP2, PGM2, UMPS | FAAH 3960/4885NPC1 3020/4885RAB9A 3015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.